California Public Employees Retirement System Trims Stock Position in Amedisys, Inc. (NASDAQ:AMED)

California Public Employees Retirement System lowered its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 29.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 115,619 shares of the health services provider's stock after selling 49,043 shares during the period. California Public Employees Retirement System owned approximately 0.35% of Amedisys worth $10,497,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. National Bank of Canada FI boosted its stake in Amedisys by 119.0% in the third quarter. National Bank of Canada FI now owns 55,592 shares of the health services provider's stock valued at $5,365,000 after acquiring an additional 30,213 shares in the last quarter. ABC Arbitrage SA acquired a new stake in shares of Amedisys in the 4th quarter worth $2,522,000. Geode Capital Management LLC grew its stake in Amedisys by 1.3% during the 3rd quarter. Geode Capital Management LLC now owns 567,105 shares of the health services provider's stock worth $54,746,000 after buying an additional 7,071 shares during the last quarter. Oddo BHF Asset Management Sas purchased a new position in Amedisys during the 3rd quarter worth $7,238,000. Finally, Empowered Funds LLC acquired a new position in Amedisys during the 4th quarter valued at about $318,000. Institutional investors own 94.36% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Stephens reissued an "equal weight" rating and issued a $101.00 price target on shares of Amedisys in a report on Tuesday, March 4th. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $101.00.

Remove Ads

Amedisys Stock Performance

Shares of AMED traded up $0.01 during trading hours on Friday, reaching $91.51. 302,927 shares of the company traded hands, compared to its average volume of 400,964. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The business has a fifty day moving average price of $92.20 and a 200-day moving average price of $92.05. Amedisys, Inc. has a 12-month low of $82.15 and a 12-month high of $98.95. The stock has a market capitalization of $3.00 billion, a P/E ratio of 36.31, a P/E/G ratio of 1.78 and a beta of 0.89.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported $0.96 EPS for the quarter, missing analysts' consensus estimates of $1.05 by ($0.09). The firm had revenue of $598.05 million for the quarter, compared to analyst estimates of $602.38 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. Equities analysts anticipate that Amedisys, Inc. will post 4.4 EPS for the current fiscal year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.